| |
People living with schizophrenia spectrum disorder (SSD) have poorer medication adherence compared to those with other mental illnesses. Long-acting injectable antipsychotic (LAI) medication use is associated with greater adherence, reduced re-hospitalizations, and improved recovery outcomes when compared to oral formulations.
|
| |
Despite high tobacco use prevalence among those with serious mental illnesses, few Assertive Community Treatment (ACT) programs provide tobacco treatment. Understanding the factors associated with the intentions to engage in tobacco treatment from both provider and consumer perspectives is important.
|
| |
The purpose of this pilot study was to evaluate the effect of a web-based education module on the knowledge, attitudes, and ratings of willingness to access help related to suicide prevention in psychiatric-mental health nurses.
|
| |
Background: Healthcare workers' risk perceptions towards contracting Coronavirus 2019 (COVID-19) may determine their adoption of preventive behaviors. The adoption of six-feet physical distancing and wearing face coverings reduces the spread of COVID-19 in the community setting. Three theoretical models, the Health Belief Model (HBM), the Protection Motivation Theory (PMT) and the Theory of Planned Behavior (TPB) have been used to determine the adoption of preventive practices in relation to infectious diseases.,
|
| |
Cigarette smoking is highly prevalent, despite being a primary preventable cause of disease and mortality.
|
| |
Tobacco use remains one of the most used substances among adults globally and substantially impacts individuals and society. Adverse childhood experiences (ACEs) contribute to tobacco use. However, the association between cumulative ACEs and tobacco use behaviors (TUB) has not been established in the literature. In this review, we aimed to estimate the prevalence of ACEs among adult tobacco users and evaluated the relationship between cumulative ACEs and TUB.
|
| |
People living with serious mental illnesses (SMI) continue to face a disproportionate burden of tobacco-related prevalence, morbidity, and mortality as compared to those without SMI. The risk of mortality related to cigarette smoking among those with SMI is six-times that for persons without SMI.
|
| |
The authors regret the following error. The second affiliation of the first author was omitted from the article. The corrected affiliations are as follows:
- State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, China;
- School of Nursing, Chengdu University of Traditional Chinese Medicine, No. 1166 Liutai Road, Wenjiang District, Chengdu City, Sichuan province 611137, China.
|
| |
In this paper we aimed to explore: (1) challenges that people with mental illnesses (MIs) describe in engaging in smoking cessation, (2) challenges that mental health providers (MHPs) perceive that people living with MIs face, and (3) how the perceived challenges are similar and/or different from both perspectives. Semi-structured interviews were used to obtain narrative data from 16 MHPs and 13 psychiatric inpatients with MIs. We identified themes purport societal, group, and individual factors may influence smoking cessation treatment engagement. The scope of the perceived challenges appeared varied in the narratives of MHPs as compared to those with MI.
|
| |
We have all likely experienced the shame, pain, and sting of being stigmatized at some point. Stigmatization appears in diverse forms-including derogatory comments about skin tone, hair texture, or body size; denial of resources due to social standing; and devaluation of persons because of sexual/gender identity, religious affiliation, or political preferences. Regardless of its form, stigmatization is never productive and poses a considerable threat to mental health and well-being.
|